Adaptive Biotechnologies ADPT
NASDAQ ADPT
$23.95 -0.07 (-0.29%)
At close: Oct 19, 2026 · 4:00 PM EDT

Adaptive Biotechnologies (ADPT) Gains from Sales and Divestitures (2018 - 2019)

Updated

Adaptive Biotechnologies (ADPT) posted Gains from Sales and Divestitures of -$388,000 for Q4 2019, compared with -$5,000 a year earlier.

Analysis

Adaptive Biotechnologies (ADPT) Gains from Sales and Divestitures (2018 - 2019) Analysis & Trends

For FY2019, Adaptive Biotechnologies' Gains from Sales and Divestitures came in at -$316,000.

  • In prior years, Adaptive Biotechnologies' Gains from Sales and Divestitures was $40,000 in FY2018 and -$125,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 100.51 Bn 96.52 Bn -
2 Natera 57.27 Bn 52.95 Bn 485.19 Mn
3 Quest Diagnostics 26.09 Bn 24.22 Bn 1.03 Bn
4 Labcorp Holdings 26.08 Bn 23.83 Bn 1.11 Bn
5 Tenet Healthcare 22.29 Bn 11.30 Bn -
6 Guardant Health 21.03 Bn 17.09 Bn 219.03 Mn
7 Fresenius Medical Care AG 12.78 Bn 4.73 Bn 1.52 Bn
8 BrightSpring Health Services 12.65 Bn 10.98 Bn 492.75 Mn
9 Davita 12.13 Bn 9.34 Bn 1.16 Bn
10 Adaptive Biotechnologies 3.82 Bn 2.82 Bn 51.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -388,000.00
Sep 30, 2019 -7,000.00
Dec 31, 2018 -5,000.00
Sep 30, 2018 4,000.00
API Access

Adaptive Biotechnologies Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ADPT&period=max&api_key=YOUR_API_KEY